Total Payments
$4,027
2024 Payments
$549.89
Companies
37
Transactions
262
Medicare Patients
4,728
Medicare Billing
$432,009
Payment Breakdown by Category
Food & Beverage$3,962 (98.4%)
Education$65.00 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,962 | 261 | 98.4% |
| Education | $65.00 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $919.98 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $432.30 | 27 | $0 (2024) |
| Lilly USA, LLC | $417.53 | 33 | $0 (2024) |
| Astellas Pharma US Inc | $343.78 | 18 | $0 (2023) |
| PFIZER INC. | $195.13 | 13 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $189.28 | 18 | $0 (2021) |
| ABBVIE INC. | $187.33 | 12 | $0 (2024) |
| Amgen Inc. | $178.06 | 12 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $173.38 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $122.77 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $549.89 | 32 | Novo Nordisk Inc ($174.96) |
| 2023 | $658.54 | 40 | Novo Nordisk Inc ($220.45) |
| 2022 | $486.90 | 33 | Novo Nordisk Inc ($107.19) |
| 2021 | $326.75 | 20 | Astellas Pharma US Inc ($76.17) |
| 2020 | $261.51 | 17 | Novo Nordisk Inc ($67.39) |
| 2019 | $527.26 | 35 | Novo Nordisk Inc ($146.64) |
| 2018 | $546.72 | 40 | Novo Nordisk Inc ($150.41) |
| 2017 | $669.12 | 45 | Lilly USA, LLC ($124.55) |
All Payment Transactions
262 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: PAIN | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Obesity | ||||||
| 08/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.85 | General |
| 08/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: VACCINES | ||||||
| 08/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Obesity | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: VACCINES | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: RESPIRATORY | ||||||
| 05/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Respiratory | ||||||
| 05/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Endocrinology | ||||||
| 04/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PAIN | ||||||
| 04/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
| 03/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,338 | 2,606 | $281,319 | $139,262 |
| 2022 | 20 | 1,129 | 2,089 | $222,647 | $79,777 |
| 2021 | 18 | 986 | 1,871 | $203,263 | $99,652 |
| 2020 | 23 | 1,275 | 2,594 | $271,443 | $113,317 |
Total Patients
4,728
Total Services
9,160
Medicare Billing
$432,009
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 331 | 632 | $104,280 | $49,100 | 47.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 129 | 602 | $58,996 | $29,388 | 49.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 151 | 308 | $34,804 | $17,660 | 50.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 104 | 104 | $16,848 | $12,470 | 74.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 105 | 105 | $13,125 | $8,089 | 61.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 65 | 99 | $12,870 | $7,900 | 61.4% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 31 | 31 | $5,797 | $2,922 | 50.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 15 | $3,495 | $2,139 | 61.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 115 | 192 | $8,448 | $1,828 | 21.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $1,900 | $1,367 | 71.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $3,496 | $1,277 | 36.5% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Office | 2023 | 22 | 22 | $2,904 | $1,221 | 42.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 58 | 115 | $5,175 | $1,062 | 20.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 12 | 12 | $1,200 | $909.72 | 75.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $800.00 | $784.00 | 98.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 11 | 12 | $2,100 | $475.75 | 22.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 43 | 87 | $1,305 | $417.50 | 32.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 43 | 160 | $3,200 | $131.24 | 4.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 30 | 36 | $576.00 | $122.76 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 260 | 522 | $86,130 | $24,132 | 28.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 102 | 468 | $45,864 | $21,555 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 133 | 268 | $30,284 | $11,068 | 36.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 50 | 85 | $11,050 | $5,086 | 46.0% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 29 | 30 | $5,610 | $2,739 | 48.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 47 | 48 | $3,600 | $2,025 | 56.2% |
About Dr. Michael Vaclaw, M.D
Dr. Michael Vaclaw, M.D is a Family Medicine healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1942295308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Vaclaw, M.D has received a total of $4,027 in payments from pharmaceutical and medical device companies, with $549.89 received in 2024. These payments were reported across 262 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,962).
As a Medicare-enrolled provider, Vaclaw has provided services to 4,728 Medicare beneficiaries, totaling 9,160 services with total Medicare billing of $432,009. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bartlesville, OK
- Active Since 09/13/2005
- Last Updated 04/29/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1942295308
Products in Payments
- Ozempic (Drug) $384.78
- MYRBETRIQ (Drug) $214.90
- JARDIANCE (Drug) $204.05
- TRULICITY (Drug) $188.18
- Rybelsus (Drug) $179.11
- Victoza (Drug) $164.13
- FARXIGA (Drug) $145.00
- MOUNJARO (Drug) $112.69
- XARELTO (Drug) $110.47
- JANUVIA (Drug) $106.64
- NURTEC ODT (Drug) $101.55
- UBRELVY (Drug) $99.28
- SYMBICORT (Drug) $99.14
- BYDUREON (Drug) $96.02
- Otezla (Drug) $84.74
- PREVNAR 20 (Biological) $80.09
- VRAYLAR (Drug) $74.46
- Wegovy (Drug) $73.95
- NEXPLANON (Drug) $58.78
- FREESTYLE LIBRE 3 (Device) $50.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bartlesville
Mark Erhardt, D.o, D.O
Family Medicine — Payments: $7,806
Family Medicine $7,806
Elizabeth Sherrock, M.d, M.D
Family Medicine — Payments: $6,925
Family Medicine $6,925
Dr. Daniel Holdman, Md, MD
Family Medicine — Payments: $5,612
Family Medicine $5,612
William Davito, D.o, D.O
Family Medicine — Payments: $4,991
Family Medicine $4,991
Ashley Estep, Do, DO
Family Medicine — Payments: $3,276
Family Medicine $3,276
Gerald Pribil, Md, MD
Family Medicine — Payments: $2,266
Family Medicine $2,266